Xiangmin Li Selected Research

Heart Failure

6/2022	The circular RNA circNlgnmediates doxorubicin-inducedcardiac remodeling and fibrosis.
1/2016	The anti-cancer components of Ganoderma lucidum possesses cardiovascular protective effect by regulating circular RNA expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangmin Li Research Topics

Disease

31	Infections 10/2023 - 09/2014
20	Neoplasms (Cancer) 04/2024 - 06/2010
5	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2015
4	Fibrosis (Cirrhosis) 01/2024 - 01/2021
4	Inflammation (Inflammations) 02/2022 - 11/2014
4	Sepsis (Septicemia) 01/2021 - 05/2015
3	Carcinogenesis 01/2024 - 06/2010
3	Cardiomyopathies (Cardiomyopathy) 06/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2010
3	Heart Arrest (Cardiac Arrest) 01/2022 - 05/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 06/2010
2	Cardiomegaly (Heart Hypertrophy) 01/2024 - 01/2021
2	Hyperglycemia 01/2023 - 02/2022
2	Rectal Neoplasms (Rectal Cancer) 01/2023 - 04/2022
2	Body Weight (Weight, Body) 09/2022 - 01/2016
2	Hyperuricemia 08/2022 - 01/2018
2	Heart Failure 06/2022 - 01/2016
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2020
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
1	Triple Negative Breast Neoplasms 04/2024
1	Mushroom Poisoning 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Heart Diseases (Heart Disease) 01/2024
1	Hepatic Encephalopathy 11/2023
1	Hemorrhage 11/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Anastomotic Leak 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Hemolytic Anemia 01/2023
1	Picornaviridae Infections 01/2023
1	Human Influenza (Influenza) 10/2022
1	Superior Mesenteric Artery Syndrome 09/2022
1	Constipation 09/2022
1	Urticaria (Hives) 08/2022
1	Gout 08/2022
1	Vomiting 06/2022
1	Exanthema (Rash) 06/2022
1	Alopecia (Baldness) 06/2022
1	Ascites 03/2022
1	Insulin Resistance 02/2022

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 10/2023 - 09/2014
10	Circular RNAIBA 01/2024 - 01/2016
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2010
10	VaccinesIBA 04/2022 - 05/2008
3	Polysaccharides (Glycans)IBA 01/2024 - 02/2022
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2017
3	IntegrinsIBA 03/2022 - 04/2017
3	HydrogenIBA 01/2022 - 05/2013
3	CytokinesIBA 12/2021 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 12/2018
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 01/2018
3	Subunit VaccinesIBA 10/2019 - 05/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2024 - 10/2017
2	Small Interfering RNA (siRNA)IBA 01/2024 - 10/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2020
2	Neutralizing AntibodiesIBA 01/2023 - 01/2021
2	Caspase 3 (Caspase-3)IBA 01/2023 - 10/2013
2	AcidsIBA 08/2022 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 10/2018
2	CreatinineIBA 01/2021 - 05/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 11/2014
2	ethyl acetateIBA 01/2020 - 11/2019
2	InterferonsIBA 08/2016 - 09/2014
1	CCAAT-Enhancer-Binding Protein-deltaIBA 04/2024
1	Vesicle-Associated Membrane Protein 3IBA 04/2024
1	Fungal PolysaccharidesIBA 01/2024
1	amatoxinIBA 01/2024
1	ganoderic acid AIBA 01/2024
1	NanovaccinesIBA 09/2023
1	pseudorabies virus glycoprotein DIBA 09/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2023
1	Chlorpromazine (Thorazine)FDA Link 01/2023
1	Chloroquine (Aralen)FDA LinkGeneric 01/2023
1	Dynamin IIIBA 01/2023
1	Clathrin Heavy ChainsIBA 01/2023
1	NitritesIBA 01/2023
1	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2023
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2023
1	Therapeutic UsesIBA 10/2022
1	6,7-dimethyl-8-ribityllumazine synthase (lumazine synthase)IBA 10/2022
1	Hemagglutinins (Hemagglutinin)IBA 10/2022
1	BenzbromaroneIBA 09/2022
1	Allopurinol (Remid)FDA LinkGeneric 09/2022
1	caffeic acid phenethyl esterIBA 08/2022
1	Xanthine OxidaseIBA 08/2022
1	Propolis (Bee Bread)IBA 08/2022
1	CarbohydratesIBA 02/2022

Therapy/Procedure

12	Therapeutics 10/2023 - 07/2015
2	Aftercare (After-Treatment) 01/2024 - 01/2016
2	Resuscitation 02/2019 - 05/2013
2	Ligation 01/2016 - 05/2015
2	Punctures 01/2016 - 05/2015
1	Transjugular Intrahepatic Portasystemic Shunt 11/2023
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2023
1	Ileostomy 01/2023
1	Colectomy 09/2022
1	Operative Surgical Procedures 04/2022